奧瑞許科技 OSUR 深 滬
等待開盤 07-19 09:30:00 美东时间
3.20
-0.080
-2.44%
華盛通- 最 高3.31
- 今 開3.31
- 成交量 85.27万股
- 最 低 3.105
- 昨 收 3.28
- 總市值 2.39亿
- 52周最高 4.92
- 市盈率 靜 --
- 換手率 1.14%
- 52周最低 2.36
- 委 比 -57.41%
- 總股本 7480.01万
- 歷史最高 23.01
- 量 比 0.82
- 振 幅 6.25%
- 歷史最低 2.36
- 每 手 1
- 風險率 0.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Orasure gets takeover bid proposal from Ron Zwanziger- Reuters
Healthcare entrepreneur Ron Zwanziger recently made an unsolicited offer to buy OraSure Technologies, a company known for its COVID-19 rapid tests, according to a report by Reuters. In June, Zwanziger...
07-15 01:58
OSS Announces $2 Million Follow-On Production Order from Innovative Medical Imaging OEM
One Stop Systems (OSS) has secured a $2 million production contract from a medical imaging OEM for non-invasive breast cancer screening. The company expects total program value to reach at least $25 million over five years. OSS will supply 65 next-generation liquid-cooled 3U-SDS systems, marking a transition from pilot to volume production. The 3U-SDS system, designed for edge AI applications, delivers datacenter-class performance in rugged, comp...
07-10 12:00
OraSure Launches Novel Blood Collection Device for Proteomic Research
OraSure Technologies launched HEMAcollect™●PROTEIN, a blood collection tube designed to stabilize plasma proteins in whole blood for up to seven days, addressing limitations of standard tubes. The product, developed by DNA Genotek, enables ambient temperature storage and transport, benefiting proteomic research in oncology, neurology, and other fields. It minimizes hemolysis and platelet activation, supporting various proteomic technologies like ...
07-10 11:05
Bayer A.G.'s eye disease treatment gets approval in China
Bayer A.G. (OTCPK:BAYZF) said on Thursday that China’s National Medical Products Administration has approved Eylea 8 mg for age-related macular degeneration treatment. The Eylea 8 mg is being jointly ...
05-22 21:40
OraSure files $300M mixed securities shelf
OraSure Technologies (NASDAQ:OSUR) filed $300M mixed securities shelf. Filing More on OraSure Technologies OraSure rises as seen benefitting from 23andMe/Regeneron deal OraSure, Targeted Genomics in p...
05-21 05:29
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
OraSure rises as seen benefitting from 23andMe/Regeneron deal
OraSure Technologies (NASDAQ:OSUR) is up ~6% Monday as it is seen as a beneficiary of Regeneron Pharmaceuticals' (NASDAQ:REGN) deal, announced earlier in the day, to purchase substantially all the ass...
05-20 00:33
Evercore ISI Group Maintains In-Line on OraSure Technologies, Maintains $3 Price Target
Evercore ISI Group analyst Vijay Kumar maintains OraSure Technologies (NASDAQ:OSUR) with a In-Line and maintains $3 price target.
05-19 23:39
Targeted Genomics, OraSure in pact for at-home celiac genetic testing
Targeted Genomics LLC announced a commercial collaboration with OraSure Technologies (NASDAQ:OSUR), the maker of ORAcollect·Dx, a saliva collection device approved for general over-the-counter use. Th...
05-14 22:03
